(1S,2R,3S,4R,5S)-4-(2-chloro-6-(methoxyamino)-9H-purin-9-yl)-2,3-dihydroxy-N-methylbicyclo[3.1.0]hexane-1-carboxamide

ID: ALA402607

PubChem CID: 44448978

Max Phase: Preclinical

Molecular Formula: C14H17ClN6O4

Molecular Weight: 368.78

Molecule Type: Small molecule

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  CNC(=O)[C@@]12C[C@@H]1[C@@H](n1cnc3c(NOC)nc(Cl)nc31)[C@H](O)[C@@H]2O

Standard InChI:  InChI=1S/C14H17ClN6O4/c1-16-12(24)14-3-5(14)7(8(22)9(14)23)21-4-17-6-10(20-25-2)18-13(15)19-11(6)21/h4-5,7-9,22-23H,3H2,1-2H3,(H,16,24)(H,18,19,20)/t5-,7-,8+,9+,14+/m1/s1

Standard InChI Key:  IDFINWOKYJJUJZ-RGUAOFKASA-N

Molfile:  

     RDKit          2D

 26 29  0  0  1  0  0  0  0  0999 V2000
   -7.4921  -10.4674    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.6671  -10.4674    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.4072   -9.6833    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -8.4397  -10.1198    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -9.1699   -9.7319    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -8.4094  -10.9443    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -9.8700  -10.1684    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.6177   -9.4273    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -7.9730  -11.1343    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -6.1762  -11.1355    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -4.5434   -8.6412    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -5.3685   -8.6423    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.2875   -9.4255    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.9559   -9.9092    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.8706  -10.7279    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -4.1174  -11.0642    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.4487  -10.5754    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -3.5374   -9.7585    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.8711   -9.2719    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -7.7396   -9.6833    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -7.0765   -9.2007    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -7.8278   -8.8687    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.4528   -8.6638    0.0000 H   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1166   -9.6058    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -4.0304  -11.8846    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
   -2.0284  -10.4261    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
 11 12  2  0
 12  8  1  0
  2  3  1  0
  4  6  2  0
 13 14  2  0
  3 21  1  0
 14 15  1  0
  5  7  1  0
 15 16  2  0
 20  1  1  0
 16 17  1  0
  3  8  1  1
 17 18  2  0
 18 13  1  0
  1  2  1  0
 18 19  1  0
 21 20  1  0
 22 21  1  0
 20 22  1  0
  1  9  1  6
 20  4  1  1
  2 10  1  6
  8 14  1  0
 21 23  1  1
 19 24  1  0
  4  5  1  0
 16 25  1  0
 13 11  1  0
 24 26  1  0
M  END

Associated Targets(Human)

ADORA1 Tclin Adenosine receptors; A1 & A3 (1051 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ADORA2A Tclin Adenosine A2a receptor (16305 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ADORA1 Tclin Adenosine A1 receptor (17603 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ADORA3 Tchem Adenosine A3 receptor (15931 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Adora1 Adenosine A1 receptor (162 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Adora3 Adenosine A3 receptor (257 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Adora2a Adenosine A2a receptor (87 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Biocomponents

Calculated Properties

Molecular Weight: 368.78Molecular Weight (Monoisotopic): 368.1000AlogP: -0.52#Rotatable Bonds: 4
Polar Surface Area: 134.42Molecular Species: NEUTRALHBA: 9HBD: 4
#RO5 Violations: HBA (Lipinski): 10HBD (Lipinski): 4#RO5 Violations (Lipinski):
CX Acidic pKa: 12.68CX Basic pKa: 0.73CX LogP: -0.67CX LogD: -0.67
Aromatic Rings: 2Heavy Atoms: 25QED Weighted: 0.42Np Likeness Score: 0.17

References

1. Melman A, Gao ZG, Kumar D, Wan TC, Gizewski E, Auchampach JA, Jacobson KA..  (2008)  Design of (N)-methanocarba adenosine 5'-uronamides as species-independent A3 receptor-selective agonists.,  18  (9): [PMID:18424135] [10.1016/j.bmcl.2008.04.001]

Source